{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:55:43Z","timestamp":1791140143251,"version":"4.1.0"},"reference-count":176,"publisher":"Bentham Science Publishers Ltd.","issue":"43","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2019,3,28]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Growing interest in the field of nanotechnology has led to its emergence in the field of medicine too.\nNanomedicines encompass the various medical tools, diagnostic agents and the drug delivery vehicles being\nevolved with the advancements in the aura of nanotechnology. This review emphasizes on providing a cursory\nliterature on the past events that led to the procession of nanomedicines, various novel drug delivery systems\ndescribing their structural features along with the pros and cons associated with them and the nanodrugs that\nmade a move to the clinical practice. It also focuses on the need of the novel drug delivery systems and the challenges\nfaced by the conventional drug delivery systems.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612825666190206222415","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T09:31:21Z","timestamp":1554111081000},"page":"5086-5107","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Nanotechnology: Revolutionizing the Science of Drug Delivery"],"prefix":"10.2174","volume":"24","author":[{"given":"Mohini","family":"Mishra","sequence":"first","affiliation":[{"name":"Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, NH-8, Bandarsindri, Ajmer, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra Singh","family":"Rajawat","sequence":"additional","affiliation":[{"name":"B. N. College of Pharmacy, B. N. University, Udaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Malik","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, NH-8, Bandarsindri, Ajmer, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gitanjali","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Modgil","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s11051-009-9607-0","volume":"11","author":"Porter A.L.","year":"2009","unstructured":"Porter AL, Youtie J.  How interdisciplinary is nanotechnology?","journal-title":"J Nanopart Res"},{"key":"ref=2","author":"Robinson JR","year":"1987","unstructured":"Robinson JR, Lee VHL.   Controlled drug delivery: Fundamentals and applications"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"406731","DOI":"10.1155\/2014\/406731","volume":"2014","author":"Raza K.","year":"2014","unstructured":"Raza K, Kumar M, Kumar P.  Topical delivery of aceclofenac: challenges and promises of novel drug delivery systems.","journal-title":"BioMed Res Int"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4103\/0378-6323.72451","volume":"76","author":"Katare O.P.","year":"2010","unstructured":"Katare OP, Raza K, Singh B, Dogra S.  Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.2174\/1381612822666160524144926","volume":"22","author":"Kumar P.","year":"2016","unstructured":"Kumar P, Raza K, Kaushik L, Malik R, Arora S, Katare OP.  Role of colloidal drug delivery carriers in taxane-mediated chemotherapy: a review.","journal-title":"Curr Pharm Des"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/0972-124X.44088","volume":"12","author":"Patil M.","year":"2008","unstructured":"Patil M, Mehta DS, Guvva S.  Future impact of nanotechnology on medicine and dentistry.","journal-title":"J Indian Soc Periodontol"},{"key":"ref=7","author":"","year":"2013","unstructured":"."},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2015.10.005","volume":"219","author":"Yun Y.H.","year":"2015","unstructured":"Yun YH, Lee BK, Park K.  Controlled drug delivery: Historical perspective for the next generation.","journal-title":"J Control Release"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2230-973X.176456","volume":"6","author":"Shah R.B.","year":"2016","unstructured":"Shah RB, Patel M, Maahs DM, Shah VN.  Insulin delivery methods: Past, present and future.","journal-title":"Int J Pharm Investig"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","volume":"148","author":"Danhier F.","year":"2010","unstructured":"Danhier F, Feron O, Pr\u00e9at V.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.","journal-title":"J Control Release"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0168-3659(90)90139-K","volume":"11","author":"Panel M.","year":"1990","unstructured":"Panel M, Yokoyama M, Miyauchi N.  Polymer micelles as novel drug carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer.","journal-title":"J Control Release"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.pharmthera.2006.05.006","volume":"112","author":"Nishiyama N.","year":"2006","unstructured":"Nishiyama N, Kataoka K.  Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery.","journal-title":"Pharmacol Ther"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0014-5793(89)81689-8","volume":"258","author":"Kabanov A.V.","year":"1989","unstructured":"Kabanov AV, Chekhonin VP, Alakhov VYu.  The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting.","journal-title":"FEBS Lett"},{"key":"ref=14","author":"Behr JP","year":"","unstructured":"Behr JP.   34 CHIMIA 5\/ (1997) Nr. 1\/2 (Jonuor\/Februor) The Proton Sponge: a Trick to Enter Cells the Viruses Did Not Exploit."},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1126\/science.283.5398.65","volume":"283","author":"Harada A.","year":"1999","unstructured":"Harada A, Kataoka K.  Chain length recognition: core-shell supramolecular assembly from oppositely charged block copolymers.","journal-title":"Science"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nchembio839","volume":"2","author":"Bumcrot D.","year":"2006","unstructured":"Bumcrot D, Manoharan M, Koteliansky V, Sah DWY.  RNAi therapeutics: A potential new class of pharmaceutical drugs.","journal-title":"Nat Chem Biol"},{"key":"ref=17","first-page":"750","volume":"7","author":"Chemmanur A.T.","year":"2006","unstructured":"Chemmanur AT, Wu GY.  Drug evaluation: Albuferon-alpha--an antiviral interferon-alpha\/albumin fusion protein.","journal-title":"Curr Opin Investig Drugs"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jconrel.2008.08.012","volume":"132","author":"Hoffman A.S.","year":"2008","unstructured":"Hoffman AS.  The origins and evolution of \u201ccontrolled\u201d drug delivery systems.","journal-title":"J Control Release"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/156720107780362339","volume":"4","author":"Malik D.K.","year":"2007","unstructured":"Malik DK, Baboota S, Ahuja A, Hasan S, Ali J.  Recent advances in protein and peptide drug delivery systems.","journal-title":"Curr Drug Deliv"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/187221109788452267","volume":"3","author":"Gupta H.","year":"2009","unstructured":"Gupta H, Bhandari D, Sharma A.  Recent trends in oral drug delivery: a review.","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"ref=21","first-page":"173","author":"Viswanathan P","year":"2017","unstructured":"Viswanathan P, Muralidaran Y, Ragavan G.","journal-title":"Challenges in oral drug delivery: a nano-based strategy to overcome"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-chembioeng-073009-100847","volume":"1","author":"Liechty W.B.","year":"2010","unstructured":"Liechty WB, Kryscio DR, Slaughter BV, Peppas NA.  Polymers for drug delivery systems.","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"ref=23","first-page":"1527","volume":"249","author":"Langer R.","year":"1990","unstructured":"Langer R.","journal-title":"New methods of drug delivery"},{"key":"ref=24","first-page":"33","author":"Bhatia S.","year":"2016","unstructured":"Bhatia S.","journal-title":"Nanoparticles Types"},{"key":"ref=25","author":"Raza K","year":"2011","unstructured":"Raza K, Singh B, Negi P.  Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.colsurfb.2012.12.043","volume":"105","author":"Raza K.","year":"2013","unstructured":"Raza K, Singh B, Singal P, Wadhwa S, Katare OP.  Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jddst.2016.09.010","volume":"37","author":"Puri A.","year":"2017","unstructured":"Puri A, Kaur A, Raza K, Goindi S, Katare OP.  Development and evaluation of topical microemulsion of dibenzoylmethane for treatment of UV induced photoaging.","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biopha.2004.02.001","volume":"58","author":"Gursoy R.N.","year":"2004","unstructured":"Gursoy RN, Benita S.  Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.","journal-title":"Biomed Pharmacother"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/10611860802228350","volume":"16","author":"Gregoriadis G.","year":"2008","unstructured":"Gregoriadis G.  Liposome research in drug delivery: The early days.","journal-title":"J Drug Target"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"10938","DOI":"10.1021\/acs.chemrev.5b00046","volume":"115","author":"Pattni B.S.","year":"2015","unstructured":"Pattni BS, Chupin VV, Torchilin VP.  New Developments in Liposomal Drug Delivery.","journal-title":"Chem Rev"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/S0006-3495(03)74989-3","volume":"84","author":"R\u00f3g T.","year":"2003","unstructured":"R\u00f3g T, Pasenkiewicz-Gierula M.  Effects of epicholesterol on the phosphatidylcholine bilayer: A molecular simulation study.","journal-title":"Biophys J"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0031-6865(95)00010-7","volume":"70","author":"Vemuri S.","year":"1995","unstructured":"Vemuri S, Rhodes CT.  Preparation and characterization of liposomes as therapeutic delivery systems: A review.","journal-title":"Pharm Acta Helv"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/026520499289220","volume":"16","author":"Cortesi R.","year":"1999","unstructured":"Cortesi R, Esposito E, Gambarin S, Telloli P, Menegatti E, Nastruzzi C.  Preparation of liposomes by reverse-phase evaporation using alternative organic solvents.","journal-title":"J Microencapsul"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/bj1860591","volume":"186","author":"Kirby C.","year":"1980","unstructured":"Kirby C, Clarke J, Gregoriadis G.  Effect of the cholesterol content of small unilamellar liposomes on their stability  and","journal-title":"Biochem J"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2005.02.021","volume":"298","author":"L\u00f3pez-Pinto J.M.","year":"2005","unstructured":"L\u00f3pez-Pinto JM, Gonz\u00e1lez-Rodr\u00edguez ML, Rabasco AM.  Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes.","journal-title":"Int J Pharm"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0006-291X(75)80433-5","volume":"63","author":"Juliano R.L.","year":"1975","unstructured":"Juliano RL, Stamp D.  The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"12875","DOI":"10.1021\/bi980096y","volume":"37","author":"Miller C.R.","year":"1998","unstructured":"Miller CR, Bondurant B, McLean SD, McGovern KA, O\u2019Brien DF.  Liposome-cell interactions : effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes.","journal-title":"Biochemistry"},{"key":"ref=38","first-page":"6831","volume":"62","author":"Campbell R.B.","year":"2002","unstructured":"Campbell RB, Fukumura D, Brown EB.  Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors.","journal-title":"Cancer Res"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1128\/AEM.68.8.3683-3690.2002","volume":"68","author":"Benech R-O.","year":"2002","unstructured":"Benech R-O, Kheadr EE, Laridi R, Lacroix C, Fliss I.  Inhibition of Listeria innocua in cheddar cheese by addition of nisin Z in liposomes or by  production in mixed culture.","journal-title":"Appl Environ Microbiol"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2008.04.004","volume":"359","author":"Shehata T.","year":"2008","unstructured":"Shehata T, Ogawara K, Higaki K, Kimura T.  Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers.","journal-title":"Int J Pharm"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"Akbarzadeh A.","year":"2013","unstructured":"Akbarzadeh A, Rezaei-Sadabady R, Davaran S.  Liposome: Classification, preparation, and applications.","journal-title":"Nanoscale Res Lett"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jcp.1040730108","volume":"73","author":"Reeves J.P.","year":"1969","unstructured":"Reeves JP, Dowben RM.  Formation and properties of thin-walled phospholipid vesicles.","journal-title":"J Cell Physiol"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.75.9.4194","volume":"75","author":"Szoka F.","year":"1978","unstructured":"Szoka F, Papahadjopoulos D, Papahadjopoulos D.  Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1081\/LPR-120039794","volume":"14","author":"Stano P.","year":"2004","unstructured":"Stano P, Bufali S, Pisano C.  Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.","journal-title":"J Liposome Res"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1749-6632.1978.tb22027.x","volume":"308","author":"Deamer D.W.","year":"1978","unstructured":"Deamer DW.  Preparation and properties of ether-injection liposomes.","journal-title":"Ann N Y Acad Sci"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-4165(78)90240-4","volume":"542","author":"Schieren H.","year":"1978","unstructured":"Schieren H, Rudolph S, Finkelstein M, Coleman P, Weissmann G.  Comparison of large unilamellar vesicles prepared by a petroleum ether vaporization method with multilamellar vesicles: ESR, diffusion and entrapment analyses.","journal-title":"Biochim Biophys Acta"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0005-2736(73)90408-2","volume":"298","author":"Batzri S.","year":"1973","unstructured":"Batzri S, Korn ED.  Single bilayer liposomes prepared without sonication.","journal-title":"Biochim Biophys Acta"},{"key":"ref=48","author":"And H.G.E.","year":"1979","unstructured":"And HGE, Strittmatter P.   Formation and properties of 1000-Adiameter,single-bilayer phospholipid vesicles (liposomes\/deoxycholate\/enzyme entrapment). vol. 76."},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1021\/bi00342a042","volume":"24","author":"Nayar R.","year":"1985","unstructured":"Nayar R, Schroit AJ.  Generation of pH-sensitive liposomes: Use of large unilamellar vesicles containing N-succinyldioleoylphosphatidylethanolamine.","journal-title":"Biochemistry"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10544-007-9046-6","volume":"9","author":"Paolino D.","year":"2007","unstructured":"Paolino D, Muzzalupo R, Ricciardi A, Celia C, Picci N, Fresta M.  \n                         and  evaluation of Bola-surfactant containing niosomes for transdermal delivery.","journal-title":"Biomed Microdevices"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s10544-009-9328-2","volume":"11","author":"Cosco D.","year":"2009","unstructured":"Cosco D, Paolino D, Muzzalupo R.  Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil.","journal-title":"Biomed Microdevices"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4103\/0110-5558.76435","volume":"1","author":"Kazi K.M.","year":"2010","unstructured":"Kazi KM, Mandal AS, Biswas N.  Niosome: A future of targeted drug delivery systems.","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.2042-7158.1992.tb03608.x","volume":"44","author":"Hofland H.E.J.","year":"1992","unstructured":"Hofland HEJ, Bouwstra JA, Verhoef JC.  Safety aspects of non-ionic surfactant vesicles: a toxicity study related to the physicochemical characteristics of non-ionic surfactants.","journal-title":"J Pharm Pharmacol"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1208\/s12249-012-9805-4","volume":"13","author":"Sezgin-Bayindir Z.","year":"2012","unstructured":"Sezgin-Bayindir Z, Yuksel N.  Investigation of formulation variables and excipient interaction on the production of niosomes.","journal-title":"AAPS PharmSciTech"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-4020-6289-6_4","author":"Sahin NO","year":"2007","unstructured":"Sahin NO.","journal-title":"Niosomes as nanocarrier systems nanomater nanosyst Biomed Appl"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-5173(99)00122-2","volume":"185","author":"Hu C.","year":"1999","unstructured":"Hu C, Rhodes DG.  Proniosomes: a novel drug carrier preparation.","journal-title":"Int J Pharm"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0005-2736(92)90154-E","volume":"1104","author":"Cevc G.","year":"1992","unstructured":"Cevc G, Blume G.  Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force.","journal-title":"Biochim Biophys Acta"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/2231-4040.85524","volume":"2","author":"Rajan R.","year":"2011","unstructured":"Rajan R, Jose S, Mukund VPB, Vasudevan DT.  Transferosomes - A vesicular transdermal delivery system for enhanced drug permeation.","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.3109\/10717544.2016.1155244","volume":"23","author":"Sharma G.","year":"2016","unstructured":"Sharma G, Goyal H, Thakur K, Raza K, Katare OP.  Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: A new therapeutic approach for pain and inflammation.","journal-title":"Drug Deliv"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1517\/17425247.3.6.727","volume":"3","author":"Benson H.A.","year":"2006","unstructured":"Benson HA.  Transfersomes for transdermal drug delivery.","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.0022-202X.2004.23441.x","volume":"123","author":"Honeywell-Nguyen P.L.","year":"2004","unstructured":"Honeywell-Nguyen PL, Gooris GS, Bouwstra JA.  Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin","journal-title":"J Invest Dermatol"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0168-3659(02)00415-7","volume":"86","author":"Honeywell-Nguyen P.L.","year":"2003","unstructured":"Honeywell-Nguyen PL, Bouwstra JA.  The  transport of pergolide from surfactant-based elastic vesicles through human skin: A suggested mechanism of action.","journal-title":"J Control Release"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v13.i3-4.30","volume":"13","author":"Cevc G.","year":"1996","unstructured":"Cevc G.  Transfersomes, liposomes and other lipid suspensions on the skin: Permeation enhancement, vesicle penetration, and transdermal drug delivery.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0168-3659(95)00056-E","volume":"36","author":"Cevc G.","year":"1995","unstructured":"Cevc G, Sch\u00e4tzlein A, Blume G.  Transdermal drug carriers: Basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides.","journal-title":"J Control Release"},{"key":"ref=65","first-page":"309","volume":"2","author":"Sachan R.","year":"2013","unstructured":"Sachan R, Parashar T, Singh V.  Drug carrier transfersomes: A novel tool for transdermal drug delivery system.","journal-title":"IJRDPL"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/0110-5558.72415","volume":"1","author":"Verma P.","year":"2010","unstructured":"Verma P, Pathak K.  Therapeutic and cosmeceutical potential of ethosomes: An overview.","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1208\/pt0804107","volume":"8","author":"Bendas E.R.","year":"2007","unstructured":"Bendas ER, Tadros MI.  Enhanced transdermal delivery of salbutamol sulfate via ethosomes.","journal-title":"AAPS PharmSciTech"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0264-410X(00)00358-3","volume":"19","author":"Jodar L.","year":"2001","unstructured":"Jodar L, Duclos P, Milstien JB, Griffiths E, Aguado MT, Clements CJ.  Ensuring vaccine safety in immunization programmes--a WHO perspective.","journal-title":"Vaccine"},{"key":"ref=69","author":"","year":"2013","unstructured":".","journal-title":"State of the world\u2019s vaccines and immunization"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2009.10.027","volume":"385","author":"Shukla A.","year":"2010","unstructured":"Shukla A, Katare OP, Singh B, Vyas SP.  M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.","journal-title":"Int J Pharm"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"59","DOI":"10.18433\/J3K01M","volume":"11","author":"Shukla A.","year":"2008","unstructured":"Shukla A, Khatri K, Gupta PN, Goyal AK, Mehta A, Vyas SP.  Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes).","journal-title":"J Pharm Pharm Sci"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","volume":"9","author":"Oyewumi M.O.","year":"2010","unstructured":"Oyewumi MO, Kumar A, Cui Z.  Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses.","journal-title":"Expert Rev Vaccines"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.drudis.2011.04.006","volume":"16","author":"De Temmerman M-L.","year":"2011","unstructured":"De Temmerman M-L, Rejman J, Demeester J, Irvine DJ, Gander B, De Smedt SC.  Particulate vaccines: on the quest for optimal delivery and immune response.","journal-title":"Drug Discov Today"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0264-410X(01)00258-4","volume":"20","author":"Clark M.A.","year":"2001","unstructured":"Clark MA, Blair H, Liang L, Brey RN, Brayden D, Hirst BH.  Targeting polymerised liposome vaccine carriers to intestinal M cells.","journal-title":"Vaccine"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1476-5381.2011.01452.x","volume":"164","author":"Shukla A.","year":"2011","unstructured":"Shukla A, Singh B, Katare OP.  Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes.","journal-title":"Br J Pharmacol"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/1061186X.2012.747528","volume":"21","author":"Wilkhu J.S.","year":"2013","unstructured":"Wilkhu JS, McNeil SE, Anderson DE, Perrie Y.  Characterization and optimization of bilosomes for oral vaccine delivery.","journal-title":"J Drug Target"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.drudis.2016.03.013","volume":"21","author":"Shukla A.","year":"2016","unstructured":"Shukla A, Mishra V, Kesharwani P.  Bilosomes in the context of oral immunization: Development, challenges and opportunities.","journal-title":"Drug Discov Today"},{"key":"ref=78","first-page":"147","volume":"3","author":"Tripathy S.","year":"2013","unstructured":"Tripathy S, Patel DK, Barob L, Naira SK.  A review on phytosomes, their characterization, advancement & potential for transdermal application.","journal-title":"J Drug Deliv Ther"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1211\/jpp.58.9.0009","volume":"58","author":"Maiti K.","year":"2006","unstructured":"Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK.  Enhanced therapeutic potential of naringenin-phospholipid complex in rats.","journal-title":"J Pharm Pharmacol"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2006.09.025","volume":"330","author":"Maiti K.","year":"2007","unstructured":"Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK.  Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats.","journal-title":"Int J Pharm"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpharm.2005.10.001","volume":"307","author":"Yanyu X.","year":"2006","unstructured":"Yanyu X, Yunmei S, Zhipeng C, Qineng P.  The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats.","journal-title":"Int J Pharm"},{"key":"ref=82","first-page":"193","volume":"10","author":"Kidd P.","year":"2005","unstructured":"Kidd P, Head K.  A review of the bioavailability and clinical efficacy of milk thistle phytosome: A silybin-phosphatidylcholine complex (Siliphos).","journal-title":"Altern Med Rev"},{"key":"ref=83","first-page":"367","volume":"73","author":"","year":"2011","unstructured":".  Jitendra, Sharma PK, Bansal S, Banik A. Noninvasive routes of proteins and peptides drug delivery.","journal-title":"Indian J Pharm Sci"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0939-6411(00)00144-2","volume":"51","author":"Veuillez F.","year":"2001","unstructured":"Veuillez F, Kalia YN, Jacques Y, Deshusses J, Buri P.  Factors and strategies for improving buccal absorption of peptides.","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/rr58","volume":"2","author":"Agu R.U.","year":"2001","unstructured":"Agu RU, Ugwoke MI, Armand M, Kinget R, Verbeke N.  The lung as a route for systemic delivery of therapeutic proteins and peptides.","journal-title":"Respir Res"},{"key":"ref=86","first-page":"69","volume":"5","author":"Lee V.H.","year":"1988","unstructured":"Lee VH.  Enzymatic barriers to peptide and protein absorption.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/187221107779814113","volume":"1","author":"Al-Tahami K.","year":"2007","unstructured":"Al-Tahami K, Singh J.  Smart polymer based delivery systems for peptides and proteins.","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1248\/bpb.29.1790","volume":"29","author":"Rawat M.","year":"2006","unstructured":"Rawat M, Singh D, Saraf S.  Nanocarriers: Promising vehicle for bioactive drugs manju.","journal-title":"Biol Pharm Bull"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.nano.2009.11.002","volume":"6","author":"Umashankar M.S.","year":"2010","unstructured":"Umashankar MS, Sachdeva RK, Gulati M.  Aquasomes: a promising carrier for peptides and protein delivery.","journal-title":"Nanomedicine (Lond)"},{"key":"ref=90","author":"Jain N.K.U.R.","year":"2006","unstructured":"Jain NKUR.","journal-title":"Jain NK UR"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1081\/DDC-100101255","volume":"26","author":"Cherian A.K.","year":"2000","unstructured":"Cherian AK, Rana AC, Jain SK.  Self-assembled carbohydrate-stabilized ceramic nanoparticles for the parenteral delivery of insulin.","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1021\/bc00035a001","volume":"6","author":"Kossovsky N.","year":"1995","unstructured":"Kossovsky N, Gelman A, Hnatyszyn HJ.  Surface-modified diamond nanoparticles as antigen delivery vehicles.","journal-title":"Bioconjug Chem"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1080\/03639040802071661","volume":"34","author":"Goyal A.K.","year":"2008","unstructured":"Goyal AK, Khatri K, Mishra N.  Aquasomes--a nanoparticulate approach for the delivery of antigen.","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/03639040701539479","volume":"34","author":"Rawat M.","year":"2008","unstructured":"Rawat M, Singh D, Saraf S, Saraf S.  Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme.","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0378-5173(02)00235-1","volume":"241","author":"Khopade A.J.","year":"2002","unstructured":"Khopade AJ, Khopade S, Jain NK.  Development of hemoglobin aquasomes from spherical hydroxyapatite cores precipitated in the presence of half-generation poly(amidoamine) dendrimer.","journal-title":"Int J Pharm"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jconrel.2005.09.051","volume":"110","author":"Mizushima Y.","year":"2006","unstructured":"Mizushima Y, Ikoma T, Tanaka J.  Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs.","journal-title":"J Control Release"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejps.2007.07.008","volume":"32","author":"Rojas-Oviedo I.","year":"2007","unstructured":"Rojas-Oviedo I, Salazar-L\u00f3pez RA, Reyes-Gasga J, Quirino-Barreda CT.  Elaboration and structural analysis of aquasomes loaded with indomethacin.","journal-title":"Eur J Pharm Sci"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.addr.2011.12.006","volume":"64","author":"Patel T.","year":"2012","unstructured":"Patel T, Zhou J, Piepmeier JM, Saltzman WM.  Polymeric nanoparticles for drug delivery to the central nervous system.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/cmdc.201402290","volume":"10","author":"Crucho C.I.C.","year":"2015","unstructured":"Crucho CIC.  Stimuli-responsive polymeric nanoparticles for nanomedicine.","journal-title":"ChemMedChem"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1021\/mp500656v","volume":"12","author":"Lin G.","year":"2015","unstructured":"Lin G, Zhang H, Huang L.  Smart polymeric nanoparticles for cancer gene delivery.","journal-title":"Mol Pharm"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1021\/bm5003009","volume":"15","author":"Zhong Y.","year":"2014","unstructured":"Zhong Y, Meng F, Deng C, Zhong Z.  Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.","journal-title":"Biomacromolecules"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","volume":"41","author":"Kamaly N.","year":"2012","unstructured":"Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation.","journal-title":"Chem Soc Rev"},{"key":"ref=103","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1039\/c3tb20191k","volume":"1","author":"Krasia-Christoforou T.","year":"2013","unstructured":"Krasia-Christoforou T, Georgiou TK.  Polymeric theranostics: using polymer-based systems for simultaneous imaging and therapy.","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=104","first-page":"3071","volume":"8","author":"Marin E.","year":"2013","unstructured":"Marin E, Brice\u00f1o MI, Caballero-George C.  Critical evaluation of biodegradable polymers used in nanodrugs.","journal-title":"Int J Nanomedicine"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2017.01.021","volume":"519","author":"Madhwi K.R.","year":"2017","unstructured":"Madhwi KR, Kumar R, Kumar P.  \n                         pharmacokinetic studies and intracellular delivery of methotrexate by means of glycine-tethered PLGA-based polymeric micelles.","journal-title":"Int J Pharm"},{"key":"ref=106","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.msec.2017.06.004","volume":"80","author":"Crucho C.I.C.","year":"2017","unstructured":"Crucho CIC, Barros MT.  Polymeric nanoparticles: A study on the preparation variables and characterization methods.","journal-title":"Mater Sci Eng C"},{"key":"ref=107","author":"Thakur CK","year":"2016","unstructured":"Thakur CK, Thotakura N, Kumar R.","journal-title":"Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1021\/acschemneuro.6b00428","volume":"8","author":"Kumar P.","year":"2017","unstructured":"Kumar P, Sharma G, Kumar R.  Enhanced brain delivery of dimethyl fumarate employing tocopherol-acetate-based nanolipidic carriers: Evidence from pharmacokinetic, biodistribution, and cellular uptake studies.","journal-title":"ACS Chem Neurosci"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2013.08.019","volume":"456","author":"Raza K.","year":"2013","unstructured":"Raza K, Singh B, Lohan S.  Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity.","journal-title":"Int J Pharm"},{"key":"ref=110","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3109\/1061186X.2012.761224","volume":"21","author":"Raza K.","year":"2013","unstructured":"Raza K, Singh B, Singla N, Negi P, Singal P, Katare OP.  Nano-lipoidal carriers of isotretinoin with anti-aging potential: formulation, characterization and biochemical evaluation.","journal-title":"J Drug Target"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2014.04.027","volume":"468","author":"Beloqui A.","year":"2014","unstructured":"Beloqui A, Solin\u00eds MA, des Rieux A, Pr\u00e9at V, Rodr\u00edguez-Gasc\u00f3n A.  Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.","journal-title":"Int J Pharm"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2017019047","volume":"34","author":"Sharma G.","year":"2017","unstructured":"Sharma G, Thakur K, Raza K, Singh B, Katare OP.  Nanostructured lipid carriers: A new paradigm in topical delivery for dermal and transdermal applications.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1021\/acschemneuro.7b00519","volume":"9","author":"Kumar P.","year":"2018","unstructured":"Kumar P, Sharma G, Gupta V.  Preclinical explorative assessment of dimethyl fumarate-based biocompatible nanolipoidal carriers for the management of multiple sclerosis.","journal-title":"ACS Chem Neurosci"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1021\/acschemneuro.7b00041","volume":"8","author":"Kumar P.","year":"2017","unstructured":"Kumar P, Sharma G, Kumar R.  Vitamin-derived nanolipoidal carriers for brain delivery of dimethyl fumarate: A novel approach with preclinical evidence.","journal-title":"ACS Chem Neurosci"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.2217\/nnm-2017-0082","volume":"12","author":"Kumar P.","year":"2017","unstructured":"Kumar P, Sharma G, Kumar R.  Stearic acid based, systematically designed oral lipid nanoparticles for enhanced brain delivery of dimethyl fumarate.","journal-title":"Nanomedicine (Lond)"},{"key":"ref=116","author":"Gohla S.","year":"","unstructured":"Gohla S.  Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 a review of the state of the art.","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"Naseri N.","year":"2015","unstructured":"Naseri N, Valizadeh H, Zakeri-Milani P.  Solid lipid nanoparticles and nanostructured lipid carriers: Structure, preparation and application.","journal-title":"Adv Pharm Bull"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1021\/acsbiomaterials.7b01031","volume":"4","author":"Kumar M.","year":"2018","unstructured":"Kumar M, Sharma G, Kumar R, Singh B, Katare OP, Raza K.  Lysine-based C 60 -fullerene nanoconjugates for monomethyl fumarate delivery: A novel nanomedicine for brain cancer cells.","journal-title":"ACS Biomater Sci Eng"},{"key":"ref=119","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/acs.molpharmaceut.6b00183","volume":"13","author":"Raza K.","year":"2016","unstructured":"Raza K, Kumar D, Kiran C.  Conjugation of docetaxel with multiwalled carbon nanotubes and codelivery with piperine: Implications on Pharmacokinetic Profile and Anticancer Activity.","journal-title":"Mol Pharm"},{"key":"ref=120","author":"","year":"","unstructured":".  Geodesic Domes | The Buckminster Fuller Institute n.d."},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.msec.2017.03.057","volume":"75","author":"Joshi M.","year":"2017","unstructured":"Joshi M, Kumar P, Kumar R.  Aminated carbon-based \u201ccargo vehicles\u201d for improved delivery of methotrexate to breast cancer cells.","journal-title":"Mater Sci Eng C"},{"key":"ref=122","first-page":"169","volume":"5","author":"Kumar M.","year":"2017","unstructured":"Kumar M, Raza K.  C60-fullerenes as drug delivery carriers for anticancer agents: Promises and hurdles.","journal-title":"Pharm Nanotechnol"},{"key":"ref=123","first-page":"1763","volume":"46","author":"Thotakura N.","year":"2018","unstructured":"Thotakura N, Sharma G, Singh B, Kumar V, Raza K.  Aspartic acid derivatized hydroxylated fullerenes as drug delivery vehicles for docetaxel: an explorative study.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijpharm.2017.07.080","volume":"530","author":"Lohan S.","year":"2017","unstructured":"Lohan S, Raza K, Mehta SK, Bhatti GK, Saini S, Singh B.  Anti-Alzheimer\u2019s potential of berberine using surface decorated multi-walled carbon nanotubes: A preclinical evidence.","journal-title":"Int J Pharm"},{"key":"ref=125","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2217\/nnm-2016-0432","volume":"12","author":"Misra C.","year":"2017","unstructured":"Misra C, Kumar M, Sharma G.  Glycinated fullerenes for tamoxifen intracellular delivery with improved anticancer activity and pharmacokinetics.","journal-title":"Nanomedicine (Lond)"},{"key":"ref=126","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.msec.2017.03.073","volume":"76","author":"Misra C.","year":"2017","unstructured":"Misra C, Thotakura N, Kumar R.  Improved cellular uptake, enhanced efficacy and promising pharmacokinetic profile of docetaxel employing glycine-tethered C-fullerenes.","journal-title":"Mater Sci Eng C"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.msec.2018.03.033","volume":"89","author":"Kumar M.","year":"2018","unstructured":"Kumar M, Sharma G, Misra C.  N-desmethyl tamoxifen and quercetin-loaded multiwalled CNTs: A synergistic approach to overcome MDR in cancer cells.","journal-title":"Mater Sci Eng C"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4103\/0975-7406.72127","volume":"2","author":"Mody V.V.","year":"2010","unstructured":"Mody VV, Siwale R, Singh A, Mody HR.  Introduction to metallic nanoparticles.","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=129","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1021\/acsbiomaterials.8b00335","volume":"4","author":"Pandey P.K.","year":"2018","unstructured":"Pandey PK, Sharma AK, Rani S, Mishra G, Kandasamy G, Patra AK.  MCM-41 Nanoparticles for Brain Delivery: Better Choline-Esterase and Amyloid Formation Inhibition with Improved Kinetics.","journal-title":"ACS Biomater Sci Eng"},{"key":"ref=130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/1556-276X-9-393","volume":"9","author":"Eatemadi A.","year":"2014","unstructured":"Eatemadi A, Daraee H, Karimkhanloo H.  Carbon nanotubes: properties, synthesis, purification, and medical applications.","journal-title":"Nanoscale Res Lett"},{"key":"ref=131","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.drudis.2016.09.013","volume":"22","author":"Sharma A.K.","year":"2017","unstructured":"Sharma AK, Gothwal A, Kesharwani P, Alsaab H, Iyer AK, Gupta U.  Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery.","journal-title":"Drug Discov Today"},{"key":"ref=132","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1039\/b309043b","volume":"33","author":"Boas U.","year":"2004","unstructured":"Boas U, Heegaard PMH.  Dendrimers in drug research.","journal-title":"Chem Soc Rev"},{"key":"ref=133","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.addr.2005.09.011","volume":"57","author":"Caminade A.M.","year":"2005","unstructured":"Caminade AM, Laurent R, Majoral JP.  Characterization of dendrimers.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=134","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1556-276X-9-247","volume":"9","author":"Abbasi E.","year":"2014","unstructured":"Abbasi E, Aval SF, Akbarzadeh A.  Dendrimers: synthesis, applications, and properties.","journal-title":"Nanoscale Res Lett"},{"key":"ref=135","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.2174\/1381612820666150827094341","volume":"21","author":"Gothwal A.","year":"2015","unstructured":"Gothwal A, Kesharwani P, Gupta U.  Dendrimers as an effective nanocarrier in cardiovascular disease.","journal-title":"Curr Pharm Des"},{"key":"ref=136","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1211\/jpp.60.6.0001","volume":"60","author":"Agarwal A.","year":"2008","unstructured":"Agarwal A, Asthana A, Gupta U, Jain NK.  Tumour and dendrimers: a review on drug delivery aspects.","journal-title":"J Pharm Pharmacol"},{"key":"ref=137","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/2211738504666160213000307","volume":"3","author":"Singh A.","year":"2016","unstructured":"Singh A, Chaudhary S, Rani S, Sharma A, Gupta L, Gupta U.  Dendrimer-drug conjugates in drug delivery and targeting.","journal-title":"Pharm Nanotechnol"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1021\/acs.molpharmaceut.7b00625","volume":"15","author":"Gothwal A.","year":"2018","unstructured":"Gothwal A, Khan I, Kumar P.  Bendamustine-PAMAM conjugates for improved apoptosis, efficacy, and  pharmacokinetics: a sustainable delivery tactic.","journal-title":"Mol Pharm"},{"key":"ref=139","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/17425247.2015.999038","volume":"12","author":"Cherniakov I.","year":"2015","unstructured":"Cherniakov I, Domb AJ, Hoffman A.  Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0169-409X(00)00103-4","volume":"45","author":"Lawrence M.J.","year":"2000","unstructured":"Lawrence MJ, Rees GD.  Microemulsion-based media as novel drug delivery systems.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=141","first-page":"327","volume":"9","author":"Patel V.","year":"2010","unstructured":"Patel V, Kukadiya H, Mashru R, Surti N, Mandal S.  Development of microemulsion for solubility enhancement of clopidogrel.","journal-title":"Iran J Pharm Res"},{"key":"ref=142","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0378-5173(95)00125-3","volume":"125","author":"Aboofazeli R.","year":"1995","unstructured":"Aboofazeli R, Patel N, Thomas M, Lawrence MJ.  Investigations into the formation and characterization of phospholipid microemulsions. IV. Pseudo-ternary phase diagrams of systems containing water-lecithin-alcohol and oil; The influence of oil.","journal-title":"Int J Pharm"},{"key":"ref=143","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/02652048.2010.546435","volume":"28","author":"Raza K.","year":"2011","unstructured":"Raza K, Negi P, Takyar S, Shukla A, Amarji B, Katare OP.  Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies.","journal-title":"J Microencapsul"},{"key":"ref=144","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/02652048.2012.717115","volume":"30","author":"Raza K.","year":"2013","unstructured":"Raza K, Katare OP, Setia A, Bhatia A, Singh B.  Improved therapeutic performance of dithranol against psoriasis employing systematically optimized nanoemulsomes.","journal-title":"J Microencapsul"},{"key":"ref=145","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1208\/s12249-015-0464-0","volume":"17","author":"Sharma G.","year":"2016","unstructured":"Sharma G, Dhankar G, Thakur K, Raza K, Katare OP.  Benzyl benzoate-loaded microemulsion for topical applications: Enhanced dermatokinetic profile and better delivery promises.","journal-title":"AAPS PharmSciTech"},{"key":"ref=146","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0169-409X(96)00490-5","volume":"25","author":"Pouton C.W.","year":"1997","unstructured":"Pouton CW.  Formulation of self-emulsifying drug delivery systems.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=147","author":"","year":"","unstructured":".  Mittal KK and S. Self emulsifying drug delivery system: a review |international journal of pharmaceutical sciences and research n.d"},{"key":"ref=148","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3109\/10717544.2011.604686","volume":"18","author":"Singh B.","year":"2011","unstructured":"Singh B, Khurana L, Bandyopadhyay S, Kapil R, Katare OOP.  Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.","journal-title":"Drug Deliv"},{"key":"ref=149","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.colsurfb.2012.06.031","volume":"101","author":"Beg S.","year":"2013","unstructured":"Beg S, Jena SS, Patra ChN.  Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.colsurfb.2012.05.019","volume":"100","author":"Bandyopadhyay S.","year":"2012","unstructured":"Bandyopadhyay S, Katare OP, Singh B.  Optimized self nano-emulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=151","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i5.10","volume":"26","author":"Singh B.","year":"2009","unstructured":"Singh B, Bandopadhyay S, Kapil R, Singh R, Katare O.  Self-emulsifying drug delivery systems (SEDDS): Formulation development, characterization, and applications.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=152","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3109\/10717544.2014.896058","volume":"22","author":"Dokania S.","year":"2015","unstructured":"Dokania S, Joshi AK.  Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.","journal-title":"Drug Deliv"},{"key":"ref=153","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3109\/10717544.2014.896058","volume":"22","author":"Dokania S.","year":"2015","unstructured":"Dokania S, Joshi AK.  Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.","journal-title":"Drug Deliv"},{"key":"ref=154","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.colsurfb.2010.05.016","volume":"79","author":"Moretton M.A.","year":"2010","unstructured":"Moretton MA, Glisoni RJ, Chiappetta DA, Sosnik A.  Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=155","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cocis.2010.10.003","volume":"16","author":"Ebrahim Attia A.B.","year":"2011","unstructured":"Ebrahim Attia AB, Ong ZY, Hedrick JL, Lee PP, Ee PLR, Hammond PT.  Mixed micelles self-assembled from block copolymers for drug delivery.","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"ref=156","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejpb.2007.03.022","volume":"66","author":"Chiappetta D.A.","year":"2007","unstructured":"Chiappetta DA, Sosnik A.  Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs.","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=157","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1166\/jbn.2015.1915","volume":"11","author":"Kahraman E.","year":"2015","unstructured":"Kahraman E, Karag\u00f6z A, Din\u00e7er S.  \u00f6zsoy Y. Polyethylenimine Modified and Non-Modified Polymeric Micelles Used for Nasal Administration of Carvedilol.","journal-title":"J Biomed Nanotechnol"},{"key":"ref=158","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejpb.2016.12.019","volume":"113","author":"Cagel M.","year":"2017","unstructured":"Cagel M, Tesan FC, Bernabeu E.  Polymeric mixed micelles as nanomedicines: Achievements and perspectives.","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=159","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1208\/s12249-016-0681-1","volume":"18","author":"Kumar P.","year":"2017","unstructured":"Kumar P, Kumar R, Singh B.  Biocompatible phospholipid-based mixed micelles for tamoxifen delivery: Promising evidences from  -  anticancer activity and dermatokinetic studies.","journal-title":"AAPS PharmSciTech"},{"key":"ref=160","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ijbiomac.2016.11.111","volume":"95","author":"Singh A.","year":"2017","unstructured":"Singh A, Thotakura N, Kumar R.  PLGA-soya lecithin based micelles for enhanced delivery of methotrexate: Cellular uptake, cytotoxic and pharmacokinetic evidences.","journal-title":"Int J Biol Macromol"},{"key":"ref=161","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.nano.2010.05.005","volume":"6","author":"Kedar U.","year":"2010","unstructured":"Kedar U, Phutane P, Shidhaye S, Kadam V.  Advances in polymeric micelles for drug delivery and tumor targeting.","journal-title":"Nanomedicine (Lond)"},{"key":"ref=162","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","volume":"33","author":"Bobo D.","year":"2016","unstructured":"Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR.  Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.","journal-title":"Pharm Res"},{"key":"ref=163","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1208\/s12248-016-9961-7","volume":"18","author":"Havel H.","year":"2016","unstructured":"Havel H, Finch G, Strode P.  Nanomedicines: From Bench to Bedside and Beyond.","journal-title":"AAPS J"},{"key":"ref=164","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bbrc.2015.08.023","volume":"468","author":"Sainz V.","year":"2015","unstructured":"Sainz V, Conniot J, Matos AI.  Regulatory aspects on nanomedicines.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=165","first-page":"742","volume":"42","author":"Ventola C.L.","year":"2017","unstructured":"Ventola CL.  Progress in nanomedicine: Approved and investigational nanodrugs.","journal-title":""},{"key":"ref=166","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2011.09.001","volume":"64","author":"Elsaesser A.","year":"2012","unstructured":"Elsaesser A, Howard CV.  Toxicology of nanoparticles.","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=167","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0079-6123(06)62013-X","volume":"162","author":"Sharma H.S.","year":"2007","unstructured":"Sharma HS, Sharma A.  Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology.","journal-title":"Prog Brain Res"},{"key":"ref=168","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2174\/1389450115666140804124808","volume":"16","author":"Wolfram J.","year":"2015","unstructured":"Wolfram J, Zhu M, Yang Y.  Safety of Nanoparticles in Medicine.","journal-title":"Curr Drug Targets"},{"key":"ref=169","author":"","year":"","unstructured":".   Nanomedicine Market."},{"key":"ref=170","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1208\/s12248-016-9970-6","volume":"18","author":"Havel H.A.","year":"2016","unstructured":"Havel HA.  Where Are the Nanodrugs? An Industry Perspective on Development of Drug Products Containing Nanomaterials.","journal-title":"AAPS J"},{"key":"ref=171","author":"","year":"2017 n.d","unstructured":".  Research C for DE and. Drug Innovation - Novel Drug Approvals for"},{"key":"ref=172","author":"Product O.","year":"","unstructured":"Product O.","journal-title":"Our Product nd"},{"key":"ref=173","author":"","year":"2017 n.d","unstructured":".  ] Research C for DE and. Drug Innovation - Novel Drug Approvals for"},{"key":"ref=174","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bbrc.2015.08.023","volume":"468","author":"Sainz V.","year":"2015","unstructured":"Sainz V, Conniot J, Matos AI.  Regulatory aspects on nanomedicines.","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=175","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","volume":"33","author":"Bobo D.","year":"2016","unstructured":"Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR.  Nanoparticle-based medicines: A review of FDA-approved materials and clinical trials to date.","journal-title":"Pharm Res"},{"key":"ref=176","doi-asserted-by":"crossref","first-page":"e1416","DOI":"10.1002\/wnan.1416","volume":"9","author":"Caster J.M.","year":"2017","unstructured":"Caster JM, Patel AN, Zhang T, Wang A.  Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T15:15:31Z","timestamp":1556118931000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169720\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":176,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2019,3,28]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612825666190206222415","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,28]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}